Genetic-testing company, (NYSE: NVTA), isn't as easy to understand as it might seem. After more than a year of pivoting and scaling down its operations, changing its leadership, and renegotiating some of its debt, there's been a lot of activity which most investors would find easy to miss.

So, let's distill the most important recent goings-on that smart investors likely perceived, but which may not have gotten the attention needed from everyone else.

Smart investors have a finger on the pulse of a company's financial health. And in Invitae's case, there are a few pressing problems.

Continue reading

Source Fool.com